Automation Pro Says India Pharmas Need To Automate More
This article was originally published in PharmAsia News
The head of an automation industry group says increased competition from China should lead Indian drug makers to step up automation of their manufacturing processes. The president of the Automation Industry Association said Indian pharmaceuticals were modernizing in other ways as they expand to global markets, but automation still is not a priority. The AIA leader said automation could become the key factor in competition. The chairman of Pharmexcil said maintenance costs and lack of timely service discouraged changeover. (Click here for more
You may also be interested in...
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.